ANI PHARMACEUTICALS INC Annual Costs and Expenses in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Ani Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from 2010 to 2024.
  • Ani Pharmaceuticals Inc Costs and Expenses for the quarter ending June 30, 2025 was $197M, a 48.6% increase year-over-year.
  • Ani Pharmaceuticals Inc Costs and Expenses for the twelve months ending June 30, 2025 was $732M, a 49.8% increase year-over-year.
  • Ani Pharmaceuticals Inc annual Costs and Expenses for 2024 was $614M, a 39.5% increase from 2023.
  • Ani Pharmaceuticals Inc annual Costs and Expenses for 2023 was $440M, a 25.1% increase from 2022.
  • Ani Pharmaceuticals Inc annual Costs and Expenses for 2022 was $352M, a 37.4% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $614M +$174M +39.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 $440M +$88.2M +25.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 $352M +$95.7M +37.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 $256M +$31.4M +14% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $224M +$34.3M +18% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $190M +$24M +14.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 $166M +$17.7M +11.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 $149M +$40M +36.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $109M +$64.9M +149% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $43.6M +$7.66M +21.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $36M +$6.78M +23.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 $29.2M +$8.77M +43% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 $20.4M -$30.9M -60.3% Jan 1, 2012 Dec 31, 2012 10-K 2014-02-28
2011 $51.4M +$5.28M +11.5% Jan 1, 2011 Dec 31, 2011 10-K 2013-02-28
2010 $46.1M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.